ArticleFrontiers in psychiatry2026
Machine learning framework for depression subtype grouping: integrating high-resolution imaging and clinical symptom analysis via correlation and clustering.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Major depressive disorder (MDD) affects approximately one in six individuals over their lifetime, with many patients experiencing treatment-resistant depression, characterized by inadequate or insufficient response from at least one antidepressant treatment. Current classification strategies for depression rely primarily on clinical assessment of symptom severity, which are prone to reader bias and test-retest variability. Moreover, these symptom-based subtypes have shown limited utility in predicting treatment response. This study introduces a data-driven, non-biased classification framework that integrates clinical features with high-resolution magnetic resonance imaging (MRI)-derived features. Using canonical correlation analysis (CCA) and hierarchical clustering, the approach identifies distinct subtypes of MDD, offering a more objective and potentially predictive alternative to traditional methods. Materials & methods: Sixty-four participants with MDD currently experiencing a major depressive episode and not currently undergoing treatment completed a battery of 11 clinical symptom severity assessments and scanned with 7T T1-weighted MRI with parameters: TE/TR = 3.62/6000 ms, 320x240x240 array size with 224x168 mm Results: CCA identified three highly correlated (r > 0.9) clinical-imaging variable pairs. The first, an anhedonia-related phenotype, showed high loadings from anhedonia severity and brainstem features. The second phenotype was associated with childhood trauma and anhedonia, with the right frontal pole as the primary imaging feature. The third phenotype linked general distress and perceived stress with the right superior temporal lobe. Hierarchical clustering along these canonical axes revealed two distinct clusters: one characterized by high childhood trauma scores and the other showing scores comparable to healthy controls. Conclusion: Taken together, this study presents a novel ML framework for classifying depression using CCA and clustering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.